We are live on
!
Find out more
GP
Geneva Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
72.91%
This Fund
S&P 500
This Quarter
Est. Return
-7.39%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
–
AUM
$70.3M
AUM Growth
-$74.6M
(-51%)
Cap. Flow
-$67M
Cap. Flow
% of AUM
-95.28%
Top 10 Holdings %
Top 10 Hldgs %
47.56%
Holding
79
New
12
Increased
10
Reduced
26
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$3.44M |
| 2 |
Netflix
NFLX
|
+$2.67M |
| 3 |
Monster Beverage
MNST
|
+$2.34M |
| 4 |
Veeva Systems
VEEV
|
+$2.05M |
| 5 |
DOCU
DocuSign
DOCU
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$6.36M |
| 2 |
SPDR Gold Trust
GLD
|
+$6.22M |
| 3 |
Walt Disney
DIS
|
+$6.01M |
| 4 |
JPMorgan Chase
JPM
|
+$5.13M |
| 5 |
Starbucks
SBUX
|
+$4.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.13% |
| 2 | Technology | 14.43% |
| 3 | Consumer Discretionary | 12.71% |
| 4 | Communication Services | 9.75% |
| 5 | Consumer Staples | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.45T
| $4.31M | 6.13% |
44,200
-3,860
| -8% | -$374K |
|
2
Alphabet (Google) Class A
GOOGL
$4.11T
| $4.02M | 5.71% |
69,160
-10,780
| -13% | -$730K |
|
3
Abbott
ABT
$188B
| $3.83M | 5.45% |
48,590
+12,374
| +34% | +$1.03M |
|
4
Microsoft
MSFT
$2.91T
| $3.68M | 5.24% |
23,350
-10,005
| -30% | -$1.65M |
|
|
5
Eli Lilly
LLY
$1.08T
| $3.47M | 4.94% |
+25,035
| New | +$3.44M |
|
6
Zoetis
ZTS
$32.6B
| $3.17M | 4.5% |
26,910
-1,850
| -6% | -$244K |
|
7
iShares Core S&P 500 ETF
IVV
$859B
| $3.01M | 4.27% |
11,632
-2,115
| -15% | -$648K |
|
|
8
Netflix
NFLX
$305B
| $2.84M | 4.04% |
+75,580
| New | +$2.67M |
|
9
PepsiCo
PEP
$196B
| $2.71M | 3.86% |
22,584
+3,202
| +17% | +$433K |
|
10
Nike
NKE
$64.2B
| $2.4M | 3.42% |
29,067
-13,150
| -31% | -$1.22M |
|
11
Fidelity Dividend ETF for Rising Rates
FDRR
$735M
| $2.22M | 3.16% |
84,288
-124,990
| -60% | -$4.09M |
|
|
12
Veeva Systems
VEEV
$33.6B
| $2.19M | 3.11% |
+13,990
| New | +$2.05M |
|
|
13
Monster Beverage
MNST
$95.1B
| $2.05M | 2.92% |
+72,944
| New | +$2.34M |
|
14
Alibaba
BABA
$276B
| $1.95M | 2.77% |
10,023
+3,583
| +56% | +$748K |
|
|
DOCU
15
DocuSign
DOCU
$11.1B
| $1.91M | 2.72% |
+20,717
| New | +$1.67M |
|
16
Medtronic
MDT
$112B
| $1.91M | 2.72% |
21,210
-8,550
| -29% | -$910K |
|
17
Thermo Fisher Scientific
TMO
$213B
| $1.89M | 2.69% |
6,665
-460
| -6% | -$145K |
|
18
Dollar General
DG
$28.3B
| $1.85M | 2.63% |
12,241
-13,349
| -52% | -$2.06M |
|
19
iShares MSCI USA Quality Factor ETF
QUAL
$45.8B
| $1.74M | 2.47% |
21,459
-15,970
| -43% | -$1.52M |
|
20
PayPal
PYPL
$50.5B
| $1.38M | 1.97% |
14,449
-12,895
| -47% | -$1.42M |
|
21
ServiceNow
NOW
$119B
| $1.22M | 1.74% |
21,300
+13,800
| +184% | +$863K |
|
22
Amgen
AMGN
$209B
| $1.17M | 1.67% |
5,785
-265
| -4% | -$57.9K |
|
23
State Street SPDR S&P 500 ETF Trust
SPY
$773B
| $1.14M | 1.62% |
4,404
-193
| -4% | -$58.9K |
|
24
Crown Castle
CCI
$34.5B
| $1.13M | 1.6% |
7,803
+2,670
| +52% | +$398K |
|
25
American Tower
AMT
$83.8B
| $1.1M | 1.57% |
5,072
+485
| +11% | +$113K |
|
Similar funds
SWM
BWM
EPG
MCP
EM
MIM
MIP
FHWM
Geneva Partners's Q1 2020 Portfolio in Review
As of Q1 2020, Geneva Partners held 79 positions worth $70.3M, down 51% from $145M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Geneva Partners withdrew a net $67M in Q1 2020, closing 31 positions and reducing 26 holdings. Its most notable exit was Vanguard High Dividend Yield ETF, an estimated $6.36M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Geneva Partners opened a new position in Eli Lilly worth $3.47M.
- Geneva Partners's largest Q1 2020 buy was Eli Lilly: 25,035 shares worth $3.47M.
- Geneva Partners added most to Abbott in Q1 2020, an estimated $1.03M increase.
- Geneva Partners's biggest Q1 2020 reduction was SPDR Gold Trust, cutting an estimated $6.22M.
- Geneva Partners fully exited Vanguard High Dividend Yield ETF in Q1 2020, selling an estimated $6.36M.
- Geneva Partners's ten largest holdings make up 48% of its $70.3M portfolio in Q1 2020.
- Geneva Partners opened 12 new positions and closed 31 in Q1 2020.
- Geneva Partners's portfolio value fell 51% quarter-over-quarter to $70.3M.
Based on Geneva Partners's 13F filing for Q1 2020, filed 27 Apr 2020.